Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Launching of the New Version of the MOPH's Website and E-Services Platform

 
The Minister of Public Health Wael Abou Faour launched the updated version of the Ministry’s website www.moph.gov.lb that comprises the completion of the electronic transactions and the publication of drugs prices in comparison with the drugs of similar composition during a press conference held at the Ministry’s premises in Bir-Hasan.
 
The Director of the National E-health Programme Lina Abou Mrad introduced the new structure of the website in details, while she noted that it was developed to keep up with the latest developments. Several elements were added to the website:
 
  1. The official website is now in both English and Arabic languages, after it was only available in English.
  1. The citizen can now be informed on everything issued by the Ministry. The electronic transactions available on the website are now categorized according to the department or subject, which makes it easier for the citizens to search for the transactions or applications.
  1. Eight transactions related to Diwan service, Pharmacy Service, Medical Professions Division and Mother and Child Health Department can be submitted and completed through the internet.
  1. A section is added for the citizens to submit complaints.
  1. The website shows the distribution of all the health care facilities in Lebanon.
  1.  The website provides a detailed description of the drugs, with a national database for the drugs registered at the Ministry and that of similar composition. This database shows all the information related to these drugs, in particular their prices, so as to allow the citizen to compare these prices and that of the drugs of similar composition.
  1.  The website includes a list of the pharmaceutical factories in Lebanon.
 
Abou Mrad added that a page on Facebook has been launched for the activities of the ministry under the title: Lebanese ministry of public health. For breaking news, the ministry can be followed on you tube and mobile app.
 
Minister Abou Faour mentioned the importance of narrowing the distance between the citizen and the state in a country like Lebanon where the gap is large between them. The main purpose of updating the website is to bridge the gap at the communication level especially that the ministry of public health is in daily contact with the citizen.
He also stressed on the importance of the publication of drug prices on the updated website, which makes it easier for the Ministry and the syndicate of pharmacists to prevent illegal pricing.
 
Minister’s decision No. 988 of 08/06/2016 on the adoption of e-services.
    ...
    121
    ...
ATC Name B/G Ingredients Dosage Form Price
L01EL01 IMBRUVICA B Ibrutinib - 140mg 140mg Tablet, film coated 194,761,649 L.L
L01EL01 DULLARMA G Ibrutinib - 140mg 140mg Capsule, hard 422,860,803 L.L
L01EL01 IMBRUVICA B Ibrutinib - 420mg 420mg Tablet, film coated 584,282,877 L.L
L01EL01 IMBRUVICA B Ibrutinib - 420mg 420mg Tablet, film coated L.L
L01EL01 DULLARMA G Ibrutinib - 140mg 140mg Capsule, hard L.L
L01EL02 CALQUENCE B Acalabrutinib - 100mg 100mg Tablet, film coated 650,653,454 L.L
L01EM03 PIQRAY B Alpelisib - 150mg 150mg Tablet, film coated 359,195,954 L.L
L01EM03 PIQRAY B Alpelisib - 200mg, Alpelisib - 50mg 150mg Tablet, film coated 359,195,954 L.L
L01EX01 SUTENT B Sunitinib maleate - 12.5mg 12.5mg Capsule 54,006,801 L.L
L01EX01 SOVIDEX G Sunitinib maleate - 12.5mg 12.5mg Capsule 36,042,560 L.L
L01EX01 SUNITINIB AQVIDA G Sunitinib maleate - 12.5mg 12.5mg Capsule, hard 41,692,397 L.L
L01EX01 SUTENT B Sunitinib maleate - 25mg 25mg Capsule 98,852,769 L.L
L01EX01 SOVIDEX G Sunitinib maleate - 25mg 25mg Capsule 64,804,314 L.L
L01EX01 SUTENT B Sunitinib maleate - 50mg 50mg Capsule 197,706,574 L.L
L01EX01 SOVIDEX G Sunitinib maleate - 50mg 50mg Capsule 118,623,323 L.L
L01EX01 SUNITINIB AQVIDA G Sunitinib maleate - 50mg 50mg Capsule, hard 151,885,541 L.L
L01EX01 SUTENT B Sunitinib maleate - 12.5mg 12.5mg Capsule L.L
L01EX01 SUTENT B Sunitinib maleate - 50mg 50mg Capsule L.L
L01EX02 NEXAVAR B Sorafenib - 200mg 200mg Tablet, film coated 86,139,938 L.L
L01EX02 NEXAVAR B Sorafenib - 200mg 200mg Tablet, film coated L.L
L01EX03 VOTRIENT B Pazopanib HCl - 400mg 400mg Tablet, film coated 72,470,021 L.L
L01EX03 VOTRIENT B Pazopanib HCl - 400mg 400mg Tablet, film coated 72,470,021 L.L
L01EX03 VOTRIENT B Pazopanib HCl - 200mg 200mg Tablet, film coated 35,112,293 L.L
L01EX03 VOTRIENT B Pazopanib HCl - 200mg 200mg Tablet, film coated 35,112,293 L.L
L01EX05 STIVARGA B Regorafenib - 40mg 40mg Tablet, film coated 264,758,436 L.L
L01EX05 STIVARGA B Regorafenib - 40mg 40mg Tablet, film coated L.L
L01EX07 CABOMETYX B Cabozantinib - 20mg 20mg Tablet, film coated 440,893,501 L.L
L01EX07 CABOMETYX B Cabozantinib - 40mg 40mg Tablet, film coated 440,893,501 L.L
L01EX07 CABOMETYX B Cabozantinib - 60mg 60mg Tablet, film coated 440,893,501 L.L
L01EX08 LENVIMA B Lenvatinib - 10mg 10mg Capsule, hard L.L
    ...
    121
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2026